Cargando…

Recent Advances in Incretin-Based Pharmacotherapies for the Treatment of Obesity and Diabetes

The incretin hormone glucagon-like peptide-1 (GLP-1) has received enormous attention during the past three decades as a therapeutic target for the treatment of obesity and type 2 diabetes. Continuous improvement of the pharmacokinetic profile of GLP-1R agonists, starting from native hormone with a h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Qiming, Akindehin, Seun E., Orsso, Camila E., Waldner, Richelle C., DiMarchi, Richard D., Müller, Timo D., Haqq, Andrea M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921987/ https://www.ncbi.nlm.nih.gov/pubmed/35299971 http://dx.doi.org/10.3389/fendo.2022.838410

Ejemplares similares

Editorial: Incretin agonists in the treatment of obesity
por: Sun, Xiaodong, et al.
Publicado: (2023)

The incretin/glucagon system as a target for pharmacotherapy of obesity
por: Del Prato, Stefano, et al.
Publicado: (2021)

Targeting the Incretin/Glucagon System With Triagonists to Treat Diabetes
por: Capozzi, Megan E, et al.
Publicado: (2018)

Anti-obesity drug discovery: advances and challenges
por: Müller, Timo D., et al.
Publicado: (2021)

Incretin hormones as immunomodulators of atherosclerosis
por: Alonso, Nuria, et al.
Publicado: (2012)

The Origin and Understanding of the Incretin Concept
por: Rehfeld, Jens F.
Publicado: (2018)

Risk Factors for Unhealthy Weight Gain and Obesity among Children with Autism Spectrum Disorder
por: Dhaliwal, Khushmol K., et al.
Publicado: (2019)

Composition and Functions of the Gut Microbiome in Pediatric Obesity: Relationships with Markers of Insulin Resistance
por: Orsso, Camila E., et al.
Publicado: (2021)

Prader–Willi-Like Phenotype Caused by an Atypical 15q11.2 Microdeletion
por: Tan, Qiming, et al.
Publicado: (2020)

NDRG1 Activity in Fat Depots Is Associated With Type 2 Diabetes and Impaired Incretin Profile in Patients With Morbid Obesity
por: Stafeev, Iurii, et al.
Publicado: (2021)

Incretin hormones and type 2 diabetes
por: Nauck, Michael A., et al.
Publicado: (2023)

Advances in Anti-obesity Pharmacotherapy: Current Treatments, Emerging Therapies, and Challenges
por: Brandfon, Skyler, et al.
Publicado: (2023)

Emerging Trend in the Pharmacotherapy of Osteoarthritis
por: Zhang, Wei, et al.
Publicado: (2019)

A Facile Procedure for One-Pot Stable Conjugation of Two Proglucagon Cysteine-Containing Peptide Analogs
por: He, Rongjun, et al.
Publicado: (2021)

From the Incretin Concept and the Discovery of GLP-1 to Today's Diabetes Therapy
por: Holst, Jens Juul
Publicado: (2019)

Exposure–Response Analysis of Cardiovascular Outcome Trials With Incretin-Based Therapies
por: Pan, Qi, et al.
Publicado: (2022)

Recent advances in pharmacotherapy of glaucoma
por: Gupta, S. K., et al.
Publicado: (2008)

Evaluation of Autonomic Nervous System Dysfunction in Childhood Obesity and Prader–Willi Syndrome
por: Richer, Lawrence P., et al.
Publicado: (2023)

Pharmacotherapy for the Treatment of Overweight and Obesity in Children, Adolescents, and Young Adults in a Large Health System in the US
por: Czepiel, Kathryn S., et al.
Publicado: (2020)

Gene x Gene Interactions Highlight the Role of Incretin Resistance for Insulin Secretion
por: Jaghutriz, Benjamin Assad, et al.
Publicado: (2019)

Anti-obesity pharmacotherapy for treatment of pediatric type 2 diabetes: Review of the literature and lessons learned from adults
por: Bensignor, Megan O., et al.
Publicado: (2022)

Beyond Glycemic Control in Diabetes Mellitus: Effects of Incretin-Based Therapies on Bone Metabolism
por: Ceccarelli, Elena, et al.
Publicado: (2013)

Impact of Incretin Hormone Receptors on Insulin-Independent Glucose Disposal in Model Experiments in Mice
por: Ovlund, Tina, et al.
Publicado: (2021)

Niacin exacerbates β cell lipotoxicity in diet-induced obesity mice through upregulation of GPR109A and PPARγ2: Inhibition by incretin drugs
por: Zhang, Xiaojing, et al.
Publicado: (2022)

Endocrine FGFs: Evolution, Physiology, Pathophysiology, and Pharmacotherapy
por: Itoh, Nobuyuki, et al.
Publicado: (2015)

Recent Advances in Obesity-Induced Inflammation and Insulin Resistance
por: Tateya, Sanshiro, et al.
Publicado: (2013)

Effects of Pharmacotherapy for the Treatment of Obesity in an Urban, Safety-Net Population
por: Kim, Eric K, et al.
Publicado: (2023)

Peptide Model of the Mutant Proinsulin Syndrome. II. Nascent Structure and Biological Implications
por: Yang, Yanwu, et al.
Publicado: (2022)

Anti-ghrelin antibodies in appetite suppression: recent advances in obesity pharmacotherapy
por: Altabas, Velimir, et al.
Publicado: (2015)

Effects of Incretin Pathway Elements on Bone Properties
por: Abdi, Arezoo M, et al.
Publicado: (2023)

The potential role of lactulose pharmacotherapy in the treatment and prevention of diabetes
por: Chu, Natural, et al.
Publicado: (2022)

Recent advances in the treatment of patients with obesity and chronic kidney disease
por: Abdul Wahab, Roshaida, et al.
Publicado: (2023)

GLP-1/glucagon receptor co-agonism for treatment of obesity
por: Sánchez-Garrido, Miguel A., et al.
Publicado: (2017)

Advances in the treatment of metabolic diseases
por: DiMarchi, Richard D.
Publicado: (2021)

Neuroprotective Effects and Treatment Potential of Incretin Mimetics in a Murine Model of Mild Traumatic Brain Injury
por: Bader, Miaad, et al.
Publicado: (2020)

Recent advances in pharmacotherapy of atrial fibrillation
por: Singh, J., et al.
Publicado: (2009)

The Complexity and Stigma of Pediatric Obesity
por: Haqq, Andrea M., et al.
Publicado: (2021)

Detour Ahead: Incretin Hormone Signaling Alters Its Intracellular Path as β-Cell Failure Progresses During Diabetes
por: Hussain, Mehboob A., et al.
Publicado: (2021)

A review on phytochemical and pharmacological facets of tropical ethnomedicinal plants as reformed DPP-IV inhibitors to regulate incretin activity
por: Chhabria, Srishti, et al.
Publicado: (2022)

Lean mass reference curves in adolescents using dual-energy x-ray absorptiometry (DXA)
por: Ripka, Wagner Luis, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1bqhrnmp4nh3qm0kj0ivpj0nbs